Diabetes Care Devices Market

Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) - Forecast to 2025

Report Code: MD 3684 Jun, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Diabetes Care Devices Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Diabetes Care Devices Market

Request For Special Pricing

[168 Pages Report] The global diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.

Diabetes Care Devices Market

The diabetes management mobile applications segment is projected to grow at the highest CAGR during the forecast period

Within the type segment, the market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The diabetes management mobile applications segment is projected to grow at the highest rate during the forecast period, driven by its convenience, simplicity of use, and utility in providing real-time insights regarding diabetic conditions to patients and healthcare professionals for integrated diabetes management.

Diabetes Care Devices Market by Region

China held the largest share in the diabetes care devices (BRIC) market.

China held the largest share in the diabetes care devices (BRIC) market in 2019. This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry. India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.

Key Market Players

The prominent players in the diabetes care devices (BRIC) market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).

Scope of the Report:

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

  • Type, end user, and country

 

Countries covered

Brazil, Russia, India, and China

Companies covered

Total 20 major players covered:
Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan)

 

The research report categorizes the market into the following segments and subsegments:

By Type

  • Blood glucose monitoring systems
  • Self-monitoring blood glucose monitoring systems
  • Continuous glucose monitoring systems
  • Test strips/Test papers
  • Lancets/Lancing devices
  • Insulin delivery devices
  • Insulin pumps
  • Insulin pens 
  • Insulin syringes and needles
  • Diabetes management mobile applications

By Country

  • Brazil
  • Russia
  • India
  • China

By End User

  • Hospitals & specialty clinics
  • Self & home care

Recent Developments

  • In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.
  • In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.
  • In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.
  • In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
  • In December 2019, Eli Lilly and Company (US) announced a global commercialization agreement to integrate DexCom, Inc.’s products into Lilly's personalized diabetes management system, currently in development, to advance the treatment of diabetes.

Critical questions the report answers:

  • Where will all these acquisitions, partnerships, agreements, and expansions take the diabetes care devices (BRIC) industry in the mid-to-long term?
  • Which are the diabetes care devices that hold the largest share in the BRIC market?
  • Which segments in the diabetes care devices market are likely to witness growth during the forecast period?
  • Which end users will benefit the most from the growth in the diabetes care devices (BRIC) market?
  • Which countries in the BRIC market are likely to grow at the highest CAGR?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 16)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 21)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary sources
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 32)

4 PREMIUM INSIGHTS (Page No. - 35)
    4.1 DIABETES CARE DEVICES MARKET OVERVIEW
    4.2 DIABETES CARE DEVICES (BRIC) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.3 DIABETES CARE DEVICES (BRIC) MARKET: COUNTRY MIX (2020–2025)

5 INDUSTRY INSIGHTS (Page No. - 38)
    5.1 INDUSTRY TRENDS
           5.1.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
           5.1.2 SMART GLUCOSE METERS ENABLE INTEGRATED DIABETES MANAGEMENT SOLUTIONS
           5.1.3 SMART INSULIN PEN SYNCHRONIZATION WITH GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING
           5.1.4 INNOVATIVE INSULIN DELIVERY SYSTEMS
    5.2 REGULATORY ANALYSIS
           5.2.1 CHINA
           5.2.2 INDIA
           5.2.3 BRAZIL
           5.2.4 RUSSIA
    5.3 COVID-19 IMPACT ON THE DIABETES CARE DEVICES (BRIC) MARKET

6 DIABETES CARE DEVICES MARKET, BY TYPE (Page No. - 46)
    6.1 INTRODUCTION
    6.2 BLOOD GLUCOSE MONITORING SYSTEMS
           6.2.1 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS
                    6.2.1.1 Technological innovations to drive the growth of self-monitoring blood glucose monitoring systems
           6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
                    6.2.2.1 Increasing collaborations, partnerships, and agreements between companies to develop integrated CGM systems to drive the growth of this market
           6.2.3 TEST STRIPS/TEST PAPERS
                    6.2.3.1 Shift toward non-invasive methods for blood glucose monitoring to restrain the growth of this market during the forecast period
           6.2.4 LANCETS/LANCING DEVICES
                    6.2.4.1 Rising focus to reduce the chances of infection and accidental pricking to increase the popularity of safety lancets during the forecast period
    6.3 INSULIN DELIVERY DEVICES
           6.3.1 INSULIN PUMPS
                    6.3.1.1 Insulin pumps integrated with continuous glucose monitoring systems offer the benefits of data integration and diabetes management
           6.3.2 INSULIN PENS
                    6.3.2.1 The convenience of use of insulin pens and increasing affordability could drive the growth of this segment during the forecast period
           6.3.3 INSULIN SYRINGES AND NEEDLES
                    6.3.3.1 Safety concerns and increasing awareness of affordable alternatives in the market could restrain the growth of this segment during the forecast period
    6.4 DIABETES MANAGEMENT MOBILE APPLICATIONS
           6.4.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS AND INCREASING AWARENESS OF DIABETES AMONG PATIENTS TO DRIVE MARKET GROWTH

7 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS (Page No. - 69)
    7.1 INTRODUCTION
    7.2 SELF/HOME HEALTHCARE
           7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES HAS FUELED THE PREFERENCE FOR SELF/HOME HEALTHCARE
    7.3 HOSPITALS & DIABETES SPECIALTY CLINICS
           7.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS BOOSTS THE MARKET GROWTH

8 DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES (Page No. - 73)
    8.1 INTRODUCTION
    8.2 CHINA: DIABETES CARE DEVICES MARKET
           8.2.1 INTRODUCTION
           8.2.2 MARKET DRIVERS
                    8.2.2.1 Sharp increase in diabetes in the past decade
                    8.2.2.2 Favorable national health strategies
                    8.2.2.3 Government-LED endorsement of the medical device industry
           8.2.3 MARKET RESTRAINTS
                    8.2.3.1 Traditional Chinese medicine as an alternative
                    8.2.3.2 High cost of advanced diabetes management devices
           8.2.4 MARKET OPPORTUNITIES
                    8.2.4.1 Significant advancements and leveraging of artificial intelligence and big data
           8.2.5 MARKET CHALLENGES
                    8.2.5.1 Lack of adherence of patients to recommended diabetes treatment guidelines
    8.3 INDIA: DIABETES CARE DEVICES MARKET
           8.3.1 INTRODUCTION
           8.3.2 MARKET DRIVERS
                    8.3.2.1 High prevalence of diabetes
                    8.3.2.2 Government’s “Make in India” campaign to encourage local manufacturing of medical devices
                    8.3.2.3 Diabetes awareness campaigns and screening camps
           8.3.3 MARKET RESTRAINTS
                    8.3.3.1 Lack of accessibility to healthcare
                    8.3.3.2 Inadequate health insurance coverage
           8.3.4 MARKET OPPORTUNITIES
                    8.3.4.1 Rising adoption of Mhealth
           8.3.5 MARKET CHALLENGES
                    8.3.5.1 Shortage of healthcare professionals in diabetes management
    8.4 BRAZIL: DIABETES CARE DEVICES MARKET
           8.4.1 INTRODUCTION
           8.4.2 MARKET DRIVERS
                    8.4.2.1 High prevalence of diabetes
                    8.4.2.2 Favorable government policies
           8.4.3 MARKET RESTRAINTS
                    8.4.3.1 Lack of awareness of diabetes care
                    8.4.3.2 High prices of advanced diabetes care devices
           8.4.4 MARKET OPPORTUNITIES
                    8.4.4.1 Increasing penetration of smartphones and rising focus on digital health to drive the growth of diabetes management platforms and diabetes management mobile applications
           8.4.5 MARKET CHALLENGES
                    8.4.5.1 Strict regulatory guidelines and regulatory process for medical devices
    8.5 RUSSIA: DIABETES CARE DEVICES MARKET
           8.5.1 INTRODUCTION
           8.5.2 MARKET DRIVERS
                    8.5.2.1 Rising elderly population
                    8.5.2.2 Increasing rate of obesity
           8.5.3 MARKET RESTRAINTS
                    8.5.3.1 Large number of undiagnosed diabetics
           8.5.4 MARKET OPPORTUNITIES
                    8.5.4.1 Government spending on healthcare
                    8.5.4.2 Rising investment of pharma market players to establish local manufacturing plants
           8.5.5 MARKET CHALLENGES
                    8.5.5.1 Low adoption of glucose monitoring systems

9 COMPETITIVE LANDSCAPE (Page No. - 100)
    9.1 OVERVIEW
    9.2 PRODUCT BENCHMARKING
    9.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2019)
    9.4 R&D EXPENDITURE: KEY PLAYERS IN THE DIABETES CARE DEVICES (BRIC) MARKET
    9.5 MARKET SHARE ANALYSIS
           9.5.1 BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
           9.5.2 RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
           9.5.3 INDIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
           9.5.4 CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS
    9.6 COMPETITIVE SITUATION AND TRENDS
           9.6.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
           9.6.2 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES

10 COMPANY PROFILES (Page No. - 115)
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
     10.1 F. HOFFMAN-LA ROCHE LTD.
     10.2 ABBOTT
     10.3 ASCENSIA DIABETES CARE HOLDINGS AG
     10.4 DEXCOM, INC.
     10.5 MEDTRONIC PLC
     10.6 B. BRAUN MELSUNGEN AG
     10.7 BECTON, DICKINSON AND COMPANY
     10.8 ACON LABORATORIES, INC.
     10.9 ARKRAY, INC.
     10.10 SANOFI
     10.11 NOVO NORDISK A/S
     10.12 TERUMO CORPORATION
     10.13 YPSOMED
     10.14 SINOCARE, INC.
     10.15 AGAMATRIX HOLDINGS LLC
     10.16 LIFESCAN
     10.17 SD BIOSENSOR, INC.
     10.18 MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD.
     10.19 DR. MOREPEN
     10.20 BIONIME CORPORATION
     10.21 ROSSMAX INTERNATIONAL LTD.

*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 161)
     11.1 INSIGHTS OF INDUSTRY EXPERTS
     11.2 DISCUSSION GUIDE
     11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.4 AVAILABLE CUSTOMIZATIONS
     11.5 RELATED REPORTS
     11.6 AUTHOR DETAILS


LIST OF TABLES (64 TABLES)

TABLE 1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE DIABETES CARE DEVICES MARKET
TABLE 2 EXCHANGE RATES UTILIZED FOR USD CONVERSION
TABLE 3 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
TABLE 4 MAJOR SMART GLUCOSE METERS AVAILABLE GLOBALLY
TABLE 5 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES IN BRIC COUNTRIES
TABLE 7 CHINA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 INDIA: MEDICAL DEVICE CLASSIFICATION
TABLE 9 BRAZIL: MEDICAL DEVICE CLASSIFICATION
TABLE 10 RUSSIA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 AVERAGE SELLING PRICE ANALYSIS OF DIABETES CARE DEVICES (BRIC MARKET)
TABLE 12 DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 13 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 18 MAJOR SELF-MONITORING BLOOD GLUCOSE METERS AVAILABLE IN BRIC COUNTRIES
TABLE 19 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 21 MAJOR CONTINUOUS GLUCOSE MONITORING SYSTEMS AVAILABLE IN BRIC COUNTRIES
TABLE 22 TEST STRIPS/TEST PAPERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 TEST STRIPS/TEST PAPERS (100 STRIPS) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 24 MAJOR TEST STRIPS/TEST PAPERS AVAILABLE IN BRIC COUNTRIES
TABLE 25 LANCETS/LANCING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 LANCETS (PER 100) & LANCING DEVICES (PER UNIT) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 27 MAJOR LANCETS/LANCING DEVICES AVAILABLE IN BRIC COUNTRIES
TABLE 28 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 29 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 INSULIN PUMPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 INSULIN PUMPS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 32 MAJOR INSULIN PUMPS AVAILABLE IN BRIC COUNTRIES
TABLE 33 INSULIN PENS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 INSULIN PENS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 35 MAJOR INSULIN PENS AVAILABLE IN BRIC COUNTRIES
TABLE 36 INSULIN SYRINGES AND NEEDLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 INSULIN SYRINGES AND NEEDLES (PER 100) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 38 INSULIN SYRINGES AND NEEDLES AVAILABLE IN BRIC COUNTRIES
TABLE 39 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 MAJOR DIABETES MANAGEMENT APPLICATIONS AVAILABLE IN BRIC COUNTRIES
TABLE 41 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 42 DIABETES CARE DEVICES MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 DIABETES CARE DEVICES MARKET FOR HOSPITAL & DIABETES SPECIALTY CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 CHINA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 CHINA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 48 INDIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 INDIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 52 BRAZIL: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 BRAZIL: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 56 RUSSIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 RUSSIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 RUSSIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 RUSSIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 60 MARKET EVALUATION MATRIX (2018–2020)
TABLE 61 BRAZIL: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019
TABLE 62 RUSSIA: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019
TABLE 63 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2019-2020)
TABLE 64 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES (2019)


LIST OF FIGURES (42 FIGURES)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 DIABETES CARE DEVICES (BRIC) MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 SELF/HOME HEALTHCARE WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE DIABETES CARE DEVICES (BRIC) MARKET
FIGURE 11 INCREASING PREVALENCE OF DIABETES AND THE GROWING DEMAND FOR NON-INVASIVE GLUCOSE MONITORING AND DIGITAL DIABETES SOLUTIONS DRIVE THE GROWTH OF THE MARKET
FIGURE 12 INDIA TO REGISTER THE FASTEST GROWTH IN THE DIABETES CARE DEVICES (BRIC) MARKET DURING THE FORECAST PERIOD
FIGURE 13 BRAZIL TO WITNESS THE SECOND-FASTEST GROWTH DURING THE FORECAST PERIOD (2020–2025)
FIGURE 14 GEOGRAPHIC SNAPSHOT: DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES
FIGURE 15 NUMBER OF ADULT DIABETICS IN CHINA (MILLION)
FIGURE 16 CHINA: DIABETES CARE DEVICES MARKET SNAPSHOT
FIGURE 17 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (0-14 YEARS) IN 2019
FIGURE 18 INDIA: DIABETES CARE DEVICES MARKET SNAPSHOT
FIGURE 19 YEAR-ON-YEAR DIABETES PREVALENCE (BRAZIL)
FIGURE 20 BRAZIL: DIABETES CARE DEVICE MARKET SNAPSHOT
FIGURE 21 POPULATION AGED ABOVE 65 YEARS AS A PERCENTAGE OF TOTAL POPULATION (RUSSIA)
FIGURE 22 RUSSIA: DIABETES CARE DEVICES MARKET SNAPSHOT
FIGURE 23 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2018 AND MAY 2020
FIGURE 24 PRODUCT PORTFOLIO ANALYSIS: DIABETES CARE DEVICES MARKET
FIGURE 25 DOMESTIC AND FOREIGN PLAYERS IN THE BRAZILIAN DIABETES CARE DEVICES MARKET
FIGURE 26 DOMESTIC AND FOREIGN PLAYERS IN THE RUSSIAN DIABETES CARE DEVICES MARKET
FIGURE 27 DOMESTIC AND FOREIGN PLAYERS IN THE INDIAN DIABETES CARE DEVICES MARKET
FIGURE 28 INDIA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 29 DOMESTIC & FOREIGN PLAYERS IN THE CHINESE DIABETES CARE DEVICES MARKET
FIGURE 30 CHINA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 31 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN 2018 AND 2020
FIGURE 32 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2019)
FIGURE 34 DEXCOM, INC.: COMPANY SNAPSHOT (2019)
FIGURE 35 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
FIGURE 38 SANOFI: COMPANY SNAPSHOT (2019)
FIGURE 39 NOVO NORDISK A/S: COMPANY SNAPSHOT (2019)
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 41 YPSOMED: COMPANY SNAPSHOT (2019)
FIGURE 42 SINOCARE, INC.: COMPANY SNAPSHOT (2019)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the diabetes care devices (BRIC) market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to the market and technology. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, presidents, vice presidents, marketing managers, product managers, sales executives, business development executives, technology & innovation directors of companies providing diabetes care devices (BRIC), and key opinion leaders in pharmaceutical companies, medical device companies, and contract research organizations.

Diabetes Care Devices Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (demand-side analysis) and top-down approach (assessment of utilization/adoption/penetration trends by type and end user).

Data Triangulation

After arriving at the market size, the total diabetes care devices (BRIC) market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, and forecast the diabetes care devices (BRIC) market by type, end user, and country
  • To provide detailed information about the factors influencing the market growth (such as drivers, opportunities, restraints, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall diabetes care devices (BRIC) market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the diabetes care devices market in Brazil, Russia, India, and China
  • To profile key players in the diabetes care devices (BRIC) market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the diabetes care devices (BRIC) market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players
Report Code
MD 3684
Published ON
Jun, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Diabetes Care Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home